InvestorsHub Logo
Followers 48
Posts 12047
Boards Moderated 0
Alias Born 09/12/2017

Re: hann-d post# 88540

Monday, 07/01/2019 10:35:34 PM

Monday, July 01, 2019 10:35:34 PM

Post# of 111073
hann- Clinical trial is already PAID FOR

Research and Development Expenses. Research and development expenses for the three-month period ended March 31, 2019, totaled $0 in comparison with $3,200, for the comparable quarter a year ago. The decrease of $3,600, or 100% is due to the completion of clinical activities associated with the erectile dysfunction trial and pre-clinical research on the Anmiostem stem cell.
https://www.sec.gov/Archives/edgar/data/1187953/000114420419027322/tv521079_10q.htm

Research and development expenses for the year ended December 31, 2018, totaled $96,621
https://www.sec.gov/Archives/edgar/data/1187953/000114420419017462/tv516069_10k.htm

Research and development expenses for the year ended December 31, 2017, totaled $260,085
https://www.sec.gov/Archives/edgar/data/1187953/000114420418017967/tv488947_10k.htm

Research and development expenses for the year ended December 31, 2016, totaled $85,334
https://www.sec.gov/Archives/edgar/data/1187953/000114420417007873/v458672_10k.htm

Total = $442,040.00

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News